Essential Partners’s scPharmaceuticals SCPH Stock Holding History

Essential Partners’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14	Closed	-$79	–	2898
2025 Q3	$79	Hold	14	–	–	﹤0.01%	2517
2025 Q2	$53	Buy	+14	New	+$43	﹤0.01%	2147

Essential Partners's SCPH Position: Q4 2025 in Review

Essential Partners sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 14 shares — an estimated $79 sold.

Essential Partners first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $79 in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Essential Partners reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Essential Partners sold 14 scPharmaceuticals shares in Q4 2025, an estimated $79.
Essential Partners first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
Essential Partners's scPharmaceuticals position peaked at $79 in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Essential Partners's 13F filing for Q4 2025, filed 21 May 2026.